The FDA rejected a new medication to treat opioid addiction that would have been implanted under the skin. The implant, Probuphine, is a long-acting version of buprenophine that is implanted under the skin of the upper arm in a procedure that can be done in a physician’s office in about 10–15 minutes.
In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available...